Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease

Clinical Rheumatology

Volumn 35, Issue 1, 2016, Pages 117-125

  Zou, Jing ^a   Chen, Jie ^a   Yan, Qingran ^a   Guo, Qiang ^a   Bao, Chunde ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Amyopathic dermatomyositis; Disease activity; Interstitial; Lung diseases; Neutrophils

Indexed keywords

CD11B ANTIGEN; CD64 ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 8; MESSENGER RNA; PROTEIN MCL 1; CHEMOKINE RECEPTOR CXCR1; IL8 PROTEIN, HUMAN; MCL1 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICALLY AMYOPATHIC DERMATOMYOSITIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOPATHOGENESIS; INTERSTITIAL LUNG DISEASE; MALE; MYOPATHY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; UPREGULATION; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PROGNOSIS; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; ANTIGENS, CD11B; CASE-CONTROL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-8; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NEUTROPHILS; PROGNOSIS; RECEPTORS, INTERLEUKIN-8A; RNA, MESSENGER; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84954372908     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-3080-1     Document Type: Article

References (44)

1. Mukae H, Ishimoto H, Sakamoto N et al (2009) Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136:1341–1347
2. Ye S, Chen XX, Lu XY et al (2007) Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 26:1647–1654
3. Ji SY, Zeng FQ, Guo Q et al (2010) Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with poly polymyositis or dermatomyositis: a retrospective study. Chin Med J (Engl) 123:517–522
4. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL (2003) Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 32:273–284
5. Ichiyasu H, Horio Y, Tsumura S et al (2014) Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases. Mod Rheumatol 24:361–365
6. Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11:519–531
7. Hallett MB, Lloyds D (1995) Neutrophil priming: the cellular signals that say ‘amber’ but not ‘green’. Immunol Today 16:264–268
8. Gono T, Kaneko H, Yasushi K et al (2014) Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology 53:2196–2203
9. Guyre PM, Campbell AS, Kniffin WD, Fanger MW (1990) Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors. J Clin Invest 86:1892–1896
10. Repp R, Valerius T, Sendler A et al (1991) Neutrophils express the high affinity receptor for IgG (FcγRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:885–889
11. Schymeinsky J, Mócsai A, Walzog B (2007) Neutrophil activation via β2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb Haemost 98:262–273
12. Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine´ myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626–636
13. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347
14. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407
15. Akira M, Hamada H, Sakatani M et al (1997) CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 168:79–83
16. Ichikado K, Suga M, Müller NL et al (2002) Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and non-survivors. Am J Respir Crit Care Med 165:1551–1556
17. Edwards SW (1996) The O-2 generating NADPH oxidase of phagocytes: structure and methods of detection. Methods 9:563–577
18. Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A et al. (2014) Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res 2014 published on 4 February 2014. doi: 10.1155/2014/290797.
19. Kotani T, Takeuchi T, Makino S et al (2011) Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia. Clin Rheumatol 30:1021–1028
20. Ando M, Miyazaki E, Yamasue M et al (2010) Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol 29:443–445
21. Zou J, Guo Q, Chi J et al. (2015) HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients. Clin Rheumatol doi: 10.1007/s10067-015-2866-5.
22. Sengeløv H, Kjeldsen L, Diamond MS, Springer TA, Borregaard N (1993) Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils. J Clin Invest 92:1467–1476
23. Montecucco F, Steffens S, Burger F et al (2008) Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways. Cell Signal 20:557–568
24. Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8:215
25. Borregaard N, Kjeldsen L, Sengeløv H et al (1994) Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 56:80–87
26. Miller LJ, Bainton DF, Borregaard N, Springer TA (1987) Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 80:535–544
27. Abram CL, Lowell CA (2009) The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 27:339–362
28. Whitlock BB, Gardai S, Fadok V, Bratton D, Henson PM (2000) Differential roles for α(M)β(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms. J Cell Biol 151:1305–1320
29. Allen TC, Kurdowska A (2014) Interleukin 8 and acute lung injury. Arch Pathol Lab Med 138:266–269
30. Puneet P, Moochhala S, Bhatia M (2005) Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 288:L3–15
31. Pelletier M, Maggi L, Micheletti A et al (2010) Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115:335–343.32
32. Lee CS, Chen TL, Tzen CY et al (2002) Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 21:391–396
33. Won Huh J, Soon Kim D, Keun Lee C et al (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101:1761–1769
34. Suda T, Fujisawa T, Enomoto N et al (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28:1005–1012
35. Laurent T, Markert M, Von Fliedner V et al (1994) CD11b/CD18 expression, adherence, and chemotaxis of granulocyte in adult respiratory distress syndrome. Am J Respir Crit Care Med 149:1534–1538
36. Robertson SE, Young JD, Kitson S et al (2006) Expression and alternative processing of IL-18 in human neutrophils. Eur J Immunol 36:722–731
37. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER (2010) Neutrophil kinetics in health and disease. Trends Immunol 31:318–324
38. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012–2020
39. Gono T, Kawaguchi Y, Hara M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology 49:1354–1360.40
40. Kell DB, Pretorius E (2014) Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics 6:748–773
41. Pham DQ, Winzerling JJ (2010) Insect ferritins: typical or atypical? Biochim Biophys Acta 1800:824–833
42. Tang X, Zhou B (2013) Ferritin is the key to dietary iron absorption and tissue iron detoxification in Drosophila melanogaster. FASEB J 27:288–298
43. Hamburger AE, West AP, Hamburger ZA, Hamburger P, Bjorkman PJ (2005) Crystal structure of a secreted insect ferritin reveals a symmetrical arrangement of heavy and light chains. J Mol Biol 349:558–569
44. Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nature Rev Immunol 6:173–182